Implications of SMAD4 Status in Pancreatic Carcinoma Treated With Radiation Therapy: A Multi-Institutional Analysis
Volume: 111, Issue: 3, Pages: S145 - S145
Published: Nov 1, 2021
Abstract
Loss of the tumor suppressor gene SMAD4 is a critical genetic alteration in pancreatic carcinoma (PC). We hypothesized that SMAD4 status in PC is associated with outcomes in patients who received neoadjuvant (NARx) or adjuvant (ARx) radiotherapy.PC patients who underwent surgical resection at two high-volume centers following NARx-or those treated with ARx-between 2008-2019 were identified. SMAD4 status was determined based on...
Paper Details
Title
Implications of SMAD4 Status in Pancreatic Carcinoma Treated With Radiation Therapy: A Multi-Institutional Analysis
Published Date
Nov 1, 2021
Volume
111
Issue
3
Pages
S145 - S145
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History